Tailored-dose chemotherapy does not improve BCRFSPharmacy Today, American Pharmacists Association, pharmacist.comResearchers from Sweden, Germany, and Austria compared outcomes in breast cancer patients who underwent either standard chemotherapy or tailored dose-dense adjuvant chemotherapy. About 2,000 women aged 65 years or younger, all with high-risk ...and more »